已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Mechanical thrombectomy in stroke patients of advanced age with score-based prediction of outcome

医学 改良兰金量表 置信区间 优势比 冲程(发动机) 内科学 缺血性中风 机械工程 工程类 缺血
作者
Nicolaj Grønbæk Laugesen,Andreas Hjelm Brandt,Trine Stavngaard,Joan Højgaard,Klaus Hansen,Thomas Truelsen
出处
期刊:Interventional Neuroradiology [SAGE Publishing]
卷期号:: 159101992211490-159101992211490 被引量:4
标识
DOI:10.1177/15910199221149073
摘要

Background Stroke patients ≥80 years constituted only 15% in randomised trials on mechanical thrombectomy (MT), but is a considerable higher proportion in clinical practice. Association of clinical variables collected before MT with functional outcome has not been independently described in these patients, while being important in the decision of patient eligibility for MT. Methods We included patients consecutively at a single centre (2017–2021) categorised as octogenarians (age: 80–89 years) or nonagenarians (age: 90–99 years). Functional outcome at 90 days was defined as fair (modified Rankin Scale (mRS) 0–3) or poor (mRS 4–6). Clinical variables collected before MT were analysed for association with shift of mRS in a poor direction. Significant predictors were used to produce a risk score of fair outcome. Significance was set at the p < 0.05 level. Results Nonagenarians (n = 43, 15.5%) compared to octogenarians (n = 235, 84.5%) less likely achieved fair outcome (20.9% vs. 46.0%, p < 0.01) with higher mortality (65.1% vs. 31.9%, p < 0.01). Significant predictors of outcome were: age, adjusted odds ratio (aOR) = 0.91 (95% confidence interval (CI): 0.86–0.97); pre-stroke mRS, aOR = 0.57 (95% CI: 0.44–0.73); National Institute of Health Stroke Scale at admission, aOR = 0.91 (95% CI: 0.87–0.95); Alberta Stroke Program Early Computed Tomography, aOR = 1.23 (95% CI: 1.05–1.45). After bootstrap validation, the area under the curve of the risk score was 0.74 and the optimal cut-off for fair outcome was a score of >7 points. Conclusions One in two octogenarians achieved fair outcome, however, only one in five nonagenarians had fair outcome. The clinical risk score could be considered as guidance when deciding patient eligibility for MT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wan关注了科研通微信公众号
1秒前
Qwer发布了新的文献求助10
1秒前
Mrmiss666完成签到,获得积分10
2秒前
郭小胖14完成签到,获得积分10
9秒前
9秒前
10秒前
14秒前
15秒前
爰爰完成签到,获得积分10
15秒前
Lch应助芭乐采纳,获得10
15秒前
chloe发布了新的文献求助10
16秒前
CodeCraft应助shauwy采纳,获得30
16秒前
17秒前
18秒前
隋利枝关注了科研通微信公众号
18秒前
晓倩发布了新的文献求助10
18秒前
20秒前
21秒前
郭菱香发布了新的文献求助10
21秒前
英俊的铭应助俊逸依丝采纳,获得10
21秒前
LYQ完成签到,获得积分10
22秒前
23秒前
wan发布了新的文献求助10
24秒前
25秒前
灰色的乌完成签到,获得积分10
25秒前
GLLHHH完成签到 ,获得积分10
26秒前
西瓜啵啵发布了新的文献求助10
26秒前
kk发布了新的文献求助10
26秒前
牛宗鹏完成签到,获得积分20
26秒前
27秒前
30秒前
羽羽发布了新的文献求助10
30秒前
31秒前
32秒前
俏皮的松鼠完成签到 ,获得积分10
34秒前
shamy发布了新的文献求助10
35秒前
脑洞疼应助可爱香槟采纳,获得10
35秒前
鲤鱼曼易完成签到,获得积分10
37秒前
隋利枝发布了新的文献求助10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6964351
求助须知:如何正确求助?哪些是违规求助? 8646385
关于积分的说明 18337528
捐赠科研通 6415579
什么是DOI,文献DOI怎么找? 3087158
关于科研通互助平台的介绍 2136918
邀请新用户注册赠送积分活动 2063658